|Bid||0.7400 x 2200|
|Ask||0.7400 x 1000|
|Day's Range||0.6612 - 0.7499|
|52 Week Range||0.6610 - 8.8800|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Next Frontier Pharmaceuticals' Subsidiary Benuvia Signs Agreement with Global Wellness' Shanti Therapeutics * Benuvia has begun focusing on Psilocybin, DMT, and MDMA. * Benuvia's 83,000 square foot synthetic compound manufacturing facility is permitted by the U.
JUPITER, FL / ACCESSWIRE / January 10, 2022 / Jupiter Wellness Issues Letter to Stockholders:Dear Fellow Stockholders,Jupiter Wellness, Inc. ("Jupiter", or the "Company"), has, we believe, accomplished big things since it became publicly traded on November 1, 2020.
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: